Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 11—November 2014
Dispatch

Hepatitis E Virus Infections in Blood Donors, France

Pierre Gallian, Sébastien Lhomme, Yves Piquet, Karine Sauné, Florence Abravanel, Azzedine Assal, Pierre Tiberghien, and Jacques IzopetComments to Author 
Author affiliations: École des Hautes Études en Santé Publique, Marseille, France (P. Gallian); Etablissement Français du Sang Alpes Méditerranée, Marseille (P. Gallian); Institut National de la Santé et de la Recherche Médicale Unite 1043, Toulouse, France (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Université Toulouse III Paul-Sabatier, Toulouse (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Institut Fédératif de Biologie, Toulouse (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Etablissement Français du Sang Aquitaine-Limousin, Bordeaux, France (Y. Piquet, A. Assal); Etablissement Français du Sang, La Plaine Saint-Denis, France (P. Tiberghien); Université de Franche-Comté, Besançon, France (P. Tiberghien)

Main Article

Table 1

Characteristics of 22 HEV RNA–positive plasma pools, France, November 27, 2012–December 1, 2013*

Pool HEV RNA, IU/mL IgG titer against HEV, U/mL IgM against HEV
P1 <60 +, <0.30 –
P2 578 +, 0.80 –
P3 3,978 +, 0.30 –
P4 415 +, 2.70 –
P5 200 +, 1.00 –
P6 <60 +, 1.10 –
P7 1,458 +, 1.60 –
P8 <60 +, 0.32 –
P9 <60 NT NT
P10 5,374 +, NT –
P11 29,796 +, 0.56 –
P12 <60 +, 1.93 –
P13 <60 +, 0.42 –
P14 <60 +, NT –
P15 2,948 +, 0.49 –
P16 171 +, 1.44 –
P17 2,137 +, 0.44 –
P18 <60 – –
P19 <60 +, 0.84 IND
P20 3,705 +, 0.26 –
P21 <60 +, 0.81 –
P22 <60 +, 2.61 –

*HEV, hepatitis E virus; +, positive; –, negative; NT, not tested because of insufficient material; IND, indeterminate.

Main Article

Page created: October 17, 2014
Page updated: October 17, 2014
Page reviewed: October 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external